Description
The Apex-Guard gamma spectroscopy application builds on Genie™ and Apex-Gamma™ software to provide enhanced controls, security, audit features, and data integrity to support compliance and quality needs of regulated count rooms.
Defensible, Ready-to-Use Radionuclide Impurity Identity and Analysis
Radioisotope producers for radiopharmaceutical applications routinely perform quality assurance measurements to demonstrate the radionuclidic purity (RNP) of their products. In gamma spectroscopy, this is achieved by evaluating the sample for impurities and demonstrating the impurities are below a percentage of the total sample activity. To accomplish this with reliability and confidence, the Apex-Guard software impurity analysis algorithm* evaluates the activity of any defined impurity radionuclide against the activity of the sample, which can be compared to a user-defined limit.
The reference sample activity can be defined in a number of ways, including externally-reported activity or from the same gamma spectroscopy measurement. For both the sample activity and the impurity activity, the Apex-Guard impurity algorithm accounts for measurement uncertainties and introduces a new metric — Maximum Potential Percent Impurity (MPPI) — providing defensible, confident reporting of the sample’s radionuclidic impurity.
*The Apex-Guard software impurity analysis algorithm is patent-pending.
**Apex-Guard Software and Mirion’s IQ/OQ Service are designed to ensure customers can meet Title 21 CFR Part 11 readily and easily. Please note that Apex-Guard software as a standalone product is not Part 11 compliant and must be integrated with processes and procedures for laboratory Part 11 compliance.